← Insider buys
ALXN

Alexion Pharmaceuticals, Inc.

EVP and Chief Compliance Officer Indrani Lall Franchini sold $170K of Alexion Pharmaceuticals, Inc.

Sold$169,696
$116.31Price
1,459Shares
−6%Stake

What ALXN did after the filing

Prices for ALXN after this filing aren't in yet.

Traded Thu, Feb 8. Filed Thu, Feb 8, 2:16 PM ET, during the session. Not investment advice.